Italia - Italia - AIFA (Agenzia Italiana del Farmaco)

ratiopharm gmbh - celecoxib - celecoxib

Italia - Italia - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - spiramicina - spiramicina

Italia - Italia - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - bacampicillina - bacampicillina

Italia - Italia - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - amoxicillina e inibitori enzimatici - amoxicillina e inibitori enzimatici

Italia - Italia - AIFA (Agenzia Italiana del Farmaco)

aurobindo pharma (italia) s.r.l. - amoxicillina e inibitori enzimatici - amoxicillina e inibitori enzimatici

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - sulfamethoxazolum, trimethoprimum - compresse - sulfamethoxazolum 800 mg, trimethoprimum 160 mg, carmellosum natricum conexum, cellulosi pulvis, maydis amylum, silica colloidalis anhydrica, gelatina, natrii laurilsulfas, talcum, magnesii stearas, pro compresso corresp. natrium max 2.86 mg. - malattie infettive - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - sulfamethoxazolum, trimethoprimum - sospensione orale - sulfamethoxazolum 200 mg, trimethoprimum 40 mg, silica colloidalis anhydrica, carmellosum natricum, dimeticonum, silica colloidalis hydrica, methylcellulosum, e 200, ethanolum 96 per centum 28.55 mg, sorbitolum liquidum cristallisabile corresp. sorbitolum 2.1 g, natrii cyclamas, saccharinum natricum, aromatica (banane) cum propylenglycolum 48 mg, aromatica (vanille), propylis parahydroxybenzoas 600 µg, e 218 5.5 mg, aqua purificata, ad suspensionem pro 5 ml corresp. natrium 12.485 mg. - malattie infettive - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

eumedica pharmaceuticals ag - sulfamethoxazolum, trimethoprimum - compresse - sulfamethoxazolum 800 mg, trimethoprimum 160 mg, carboxymethylamylum natricum a, povidonum k 30, magnesii stearas, natrii docusas, pro compresso corresp. natrium 1.1 mg. - malattie infettive - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - pantoprazolum - compressa gastroresistente - pantoprazolum 20 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 29.25 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum k 25, propylenglycolum, e 171, e 172 (flavum), acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, e 210 <0.65 µg, e 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 3.58 mg. - ulcustherapie, refluxoesophagitis, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - pantoprazolum - compressa gastroresistente - pantoprazolum 40 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 58.5 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum k 25, propylenglycolum, e 171, e 172, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, e 210 < 1.3 µg, e 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 7.17 mg. - ulcustherapie, refluxoesophagitis, sindrome di zollinger-ellison-syndrom - synthetika